C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2006
11/16/2006	US20060258596 Antimicrobial agents
11/16/2006	US20060258595 Apoptosis of rectum and prostate gland cancer
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060258593 Methods and compositions for the treatment of gastrointestinal disorders
11/16/2006	US20060258577 Antiviral agents for the treatment, control and prevention of infections by coronaviruses
11/16/2006	US20060258576 Gdnf-related neuropeptides
11/16/2006	US20060258566 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/16/2006	US20060258564 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines
11/16/2006	US20060257980 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
11/16/2006	US20060257973 Pseudomycin production by pseudomonas syringae
11/16/2006	US20060257318 Method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
11/16/2006	CA2607142A1 Personal care compositions and methods for their use
11/16/2006	CA2606287A1 Peptide
11/15/2006	EP1722227A2 Epitopes formed by non-covalent association of conjugates
11/15/2006	EP1721978A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
11/15/2006	EP1720898A2 Antihypertensive peptides from casein hydrolysates
11/15/2006	EP1720575A2 Therapeutic and diagnostic conjugates for use with multispecific antibodies
11/15/2006	EP1517997A4 Luminogenic protease substrates
11/15/2006	CN1863815A Polypeptides having brain disposition activity and utilization of the same
11/15/2006	CN1863558A Polyarginine-modified liposome capable of transferring into nucleus
11/15/2006	CN1863506A Methods for preparing oil bodies comprising active ingredients
11/15/2006	CN1863501A Peptide-based conditioners and colorants for hair, skin, and nails
11/14/2006	US7135566 for antitumor/anti-inflammatory/viricide drugs
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135548 Having antimicrobial activity
11/14/2006	US7135461 Retro-inverso peptides derived from interleukin-6
11/14/2006	US7135457 Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
11/14/2006	US7135453 Reagents and methods for smooth muscle therapies
11/14/2006	US7135280 Assay to determine efficacy of treatment for mycobacterial infection
11/14/2006	US7135185 Conserved motif of hepatitis C virus E2/NS1 region
11/14/2006	CA2139571C Interferon receptor binding peptides
11/09/2006	WO2006117011A1 Dye conjugates of template-fixed peptidomimetics
11/09/2006	WO2006116874A1 Compositions and methods for modulating dopamine neurotransmission
11/09/2006	WO2006070432B1 Anti-tumoral immunogenic peptides and vaccine thereof
11/09/2006	US20060252930 Fki-1366 substances and process for producing the same
11/09/2006	US20060252915 Inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity
11/09/2006	US20060252697 Compounds that bind to growth hormone receptor
11/09/2006	US20060252694 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/09/2006	US20060252116 Icam-4 binding sites
11/09/2006	US20060252109 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251699 Anti-angiogenic peptides from the N-terminus of endostatin
11/09/2006	CA2607095A1 Compositions and methods for modulating dopamine neurotransmission
11/08/2006	EP1719520A1 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use
11/08/2006	EP1718977A1 Protein phosphorylation in t-cell receptor signaling pathways
11/08/2006	EP1718760A1 Protein phosphorylation in c-src signaling pathways
11/08/2006	EP1718670A1 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonist/antagonist activity
11/08/2006	EP1718669A1 Identification of novel ige epitopes
11/08/2006	EP1718323A2 Binding peptidomimetics and uses of the same
11/08/2006	EP1263800B1 Linker based solid support for peptide and small molecule organic synthesis
11/08/2006	CN1860129A Novel peptide ligands of leukocyte integrins
11/08/2006	CN1860128A Novel melanocortin receptor agonists
11/08/2006	CN1858060A Process for preparing solid phase polypeptide synthetic eptifibatide
11/08/2006	CN1858059A Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use
11/08/2006	CN1283659C Truncated glial cell line-derived neurotrophic factor
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132506 Peptide having osteogenetic activity and osteogenetic accelerator containing the same
11/07/2006	US7132475 Synthesis of preerential block copolymers; provide chemical intermediates, generate polymeric thiol, polymerize second compound which contains episulfide, recover block copolymer
11/07/2006	US7132401 Beta-secretase substrates and uses thereof
11/07/2006	US7132392 administering to mammals peptides having angiostatic activity, that inhibit hepatocyte growth factor induced cell migration and binding between intracellular transducers and receptor protein tyrosine kinases; anticarcinogenic agents
11/07/2006	US7132243 Propagation lymphocytes; obtain cells, incubate in nutrient broth, propagate recover cells
11/05/2006	WO2006103110A1 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
11/02/2006	WO2006115230A1 Compound having amino acid residue or peptide residue and process for producing the same
11/02/2006	WO2006114799A1 Synthetic peptides for the diagnosis and therapy of berillium granulomatous disease
11/02/2006	WO2006114478A1 Diagnostic and therapeutic agents
11/02/2006	WO2006114324A1 Compounds comprising cyclized somatostatin receptor binding peptides
11/02/2006	WO2006114323A2 Orthogonally protected bifunctional amino acid
11/02/2006	WO2006114039A1 Method for separating nisin from fermantation liquid of lactic galactococcus
11/02/2006	WO2006032909A3 Pka ii anchoring disruption polypeptide
11/02/2006	WO2005095442A8 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
11/02/2006	WO2005049638A3 Amniotic-derived peptide and uses thereof
11/02/2006	US20060247417 Labelling peptides with hydrazide/hydrazine moieties
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	US20060247175 Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient
11/02/2006	US20060247157 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
11/02/2006	US20060246585 Nucleic acid complex and method of introducing nucleic acid into cell using the same
11/02/2006	US20060246426 Recombinant fusion proteins with high affinity binding to gold and applications thereof
11/02/2006	EP1717249A1 Peptides containing a cholesterol recognition sequence and their uses
11/02/2006	EP1717247A1 Cyclic peptides binding to the somatostatin receptor
11/02/2006	EP1717244A1 Akt activity specifically inhibiting polypeptide
11/02/2006	EP1717219A1 Orthogonally protected bifunctional amino acid
11/02/2006	EP1716419A2 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility.
11/02/2006	EP1006785B1 Antimicrobial proteins
11/02/2006	CA2605931A1 Diagnostic and therapeutic agents
11/01/2006	CN1856504A Anti-infarction molecules
11/01/2006	CN1856503A Peptide originating in hepatitis c virus
11/01/2006	CN1854151A Dopamine transfer protein peptide inhibitor and its use
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
11/01/2006	CN1282658C Novel peptide, novel adsorbent, adsorption unit and adsorption method
10/2006
10/31/2006	US7129334 Polypeptides; from snake venom; wound healing agents
10/31/2006	US7129326 Methods for selective targeting
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129226 Mimetic insect allatostatin analogs for insect control
10/31/2006	US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
10/31/2006	US7129213 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
10/31/2006	US7129208 Synthetic ion channels
10/31/2006	US7128896 using carbocyanine dyes; photodynamic therapy; in vivo supplying to tumor
10/26/2006	WO2006112738A1 Novel peptides and methods for the treatment of inflammatory disorders
10/26/2006	WO2006111616A1 Peptide vaccine for influenza virus
10/26/2006	WO2006111060A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta

1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 423